Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2015 R21 RFA-CA-14-003 HALL, ADAM ROGER WAKE FOREST UNIVERSITY HEALTH SCIENCES MOLECULAR DETECTION OF DNA HYDROXYMETHYLATION FOR CANCER SCREENING Complete
2018 R21 RFA-CA-17-010 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Optogenetic tools for the dissection of oncogenic signaling mediated by kinases Complete
1999 R21 PAR-98-067 SINGER, ROBERT H YESHIVA UNIVERSITY FISH AND CHIPS--SINGLE CELL EXPRESSION OF CANCER GENES Complete
2001 R33 PAR-99-100 FU, XIANG-DONG UNIVERSITY OF CALIFORNIA SAN DIEGO CANCER CLASSIFICATION BASED ON MRNA ISOFORMS Complete
2004 R21 PAR-01-104 ZHAO, YINGMING UNIVERSITY OF TEXAS SW MED CTR/DALLAS A NOVEL PROTEOMICS TECHNOLOGY FOR PROTEIN FARNESYLATION Complete
2007 R21 RFA-CA-07-015 ANDREEV, OLEG A UNIVERSITY OF RHODE ISLAND NEW TECHNOLOGY FOR SELECTIVE DELIVERY OF PNAS IN CANCER CELLS IN VITRO AND IN VIV Complete
2010 R21 RFA-CA-09-006 RICHARDSON, ADAM DAVID SANFORD-BURNHAM MEDICAL RESEARCH INSTIT FUNCTIONAL METABOLOMICS AND METABOLIC FLUX ANALYSIS IN CANCER Complete
2014 R21 RFA-CA-13-001 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY IMPLANTABLE DEVICE FOR HIGH-THROUGHPUT IN VIVO DRUG SENSITIVITY TESTING Complete
2017 R21 RFA-CA-16-001 WONG, IAN Y BROWN UNIVERSITY High Content Screening of Multicellular Invasion with 3D Traction Force Microscopy Complete
2000 R44 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING Complete
2002 R44 PAR-01-105 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS Complete
2006 R33 RFA-CA-06-004 CHU, WEI-SING AMERICAN REGISTRY OF PATHOLOGY, INC. ULTRASOUND-ACCELERATED TISSUE FORMALIN FIXATION AND PARAFFIN EMBEDDING Complete
2009 R21 RFA-CA-08-007 SHEN, LANLAN UNIVERSITY OF TX MD ANDERSON CAN CTR MASSIVELY PARALLEL SEQUENCING TECHNOLOGY FOR CANCER EPIGENOME. Complete
2013 R21 RFA-CA-12-002 QUINN, THOMAS P. UNIVERSITY OF MISSOURI-COLUMBIA IN VIVO METAL-FREE CYCLOADDITION CHEMISTRY DRIVEN PRETARGETED CANCER RADIOTHERAPY Complete
2016 R33 RFA-CA-15-003 SIMS, PETER ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES LARGE-SCALE INTEGRATION OF SINGLE CELL RNA-SEQ AND HIGH-CONTENT IMAGING FOR ANALYZING DRUG RESPONSE IN CANCER Complete
2020 R21 RFA-CA-19-019 CICERONE, MARCUS T GEORGIA INSTITUTE OF TECHNOLOGY Label-Free Cell-Resolved Metabolomics for Tumor Microscopy Complete
2000 R21 PAR-99-102 GALE, JAMES M UNIVERSITY OF NEW MEXICO MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER Complete
2002 R33 PAR-99-100 GUO, BAOCHUAN CLEVELAND STATE UNIVERSITY MALDI TOF TECHNOLOGY FOR MOLECULAR ANALYSIS OF CANCER Complete
2005 R43 RFA-CA-05-007 PHILIP, RAMILA IMMUNOTOPE, INC. IDENTIFICATION OF AUTO ANTIGENS IN OVARIAN CANCER Complete
2008 R43 RFA-CA-07-041 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC QUANTITATIVE PROTEOMICS OF METASTASIS Complete
2011 R33 RFA-CA-10-004 GARRAWAY, LEVI A DANA-FARBER CANCER INST HIGH-THROUGHPUT TUMOR GENOMIC PROFILING BY MASSIVELY PARALLEL SEQUENCING Complete
2015 R33 RFA-CA-14-006 BROWN, JONATHAN QUINCY TULANE UNIVERSITY OF LOUISIANA IMPROVING BIOSPECIMEN QUALITY BY VERIFYING ADEQUACY AT THE POINT-OF-ACQUISITION WITH EX VIVO STRUCTURED ILLUMINATION MICROSCOPY Complete
2019 R21 RFA-CA-18-002 WARREN, CHRISTOPHER L PROTEOVISTA, LLC SNAP-X: Development of a Mutagenesis Strategy and High Density Protein Array to Comprehensively Display Protein Variants Complete
1999 R43 PAR-98-066 WINZER-SERHAN, URSULA H AMBION, INC. DEVELOPMENT OF RNA FRIENDLY, HISTOLOGICAL FIXATIVES Complete
2002 R21 PAR-01-106 DYNAN, WILLIAM S MEDICAL COLLEGE OF GEORGIA (MCG) LASER CAPTURE MICROSCOPY AND 2D-DIGE: CANCER PROTEOMICS Complete
2005 R21 RFA-CA-05-002 KELLEY, SHANA O BOSTON COLLEGE NANOSCALE ELECTROCATALYTIC PROTEIN DETECTION Complete
2008 R21 RFA-CA-07-033 KELLEY, SHANA O UNIVERSITY OF TORONTO DEVELOPMENT OF DNA-TEMPLATED IR QUANTUM DOTS Complete
2011 R21 RFA-CA-10-003 EVANS, CONOR LEE MASSACHUSETTS GENERAL HOSPITAL HYPERSPECTRAL AND STRUCTURAL MICROSCOPY PLATFORM FOR THERAPY OF RESISTANT CANCER Complete
2015 R21 RFA-CA-14-003 WILLIAMS, JOHN CHARLES BECKMAN RESEARCH INSTITUTE/CITY OF HOPE IN SITU IMAGING OF CAR T-CELLS Complete
2018 R21 RFA-CA-17-010 MAILLOUX, ADAM WILLIAM H. LEE MOFFITT CANCER CTR & RES INST Autohistomagnetic Isolation of Tumor-reactive T-cells Complete
1999 R21 PAR-98-067 SHACKNEY, STANLEY E ALLEGHENY-SINGER RESEARCH INSTITUTE MOLECULAR PROFILING OF CELLS BY LASER SCANNING CYTOMETRY Complete
2001 R33 PAR-99-102 BOSS, GERRY R UNIVERSITY OF CALIFORNIA SAN DIEGO AUTOMATED MEASUREMENT OF RAS & RHO ACTIVATION IN CANCER Complete
2004 R21 PAR-01-104 REN, BING LUDWIG INSTITUTE FOR CANCER RESEARCH TRANSCRIPTION FACTOR TARGET MAPPING IN MAMMALIAN GENOME Complete
2007 R21 RFA-CA-07-015 REICH, DANIEL H JOHNS HOPKINS UNIVERSITY MAGNETICALLY PATTERNED CO-CULTURES FOR CANCER STUDIES Complete
2010 R21 RFA-CA-09-006 TURK, BENJAMIN E YALE UNIVERSITY GLOBAL PEPTIDE MICROARRAY PROFILING OF TYROSINE KINASES DEREGULATED IN CANCER Complete
2014 R21 RFA-CA-13-001 ZAIA, JOSEPH BOSTON UNIVERSITY MEDICAL CAMPUS QUANTITATIVE PROFILING OF GLYCOSAMINOGLYCANS FROM BREAST TUMOR TISSUE ARRAYS Complete
2017 R21 RFA-CA-16-001 KESHARI, KAYVAN R. SLOAN-KETTERING INST CAN RESEARCH uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells Complete
2000 R44 PAR-98-066 ANDERSON, N LEIGH LARGE SCALE BIOLOGY CORPORATION PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH Complete
2003 R21 PAR-01-104 FERRARI, MAURO OHIO STATE UNIVERSITY NANOMECHANICAL METHOD FOR MOLECULAR ANALYSIS OF CANCER Complete
2006 R33 RFA-CA-06-004 LANDERS, JAMES P UNIVERSITY OF VIRGINIA CHARLOTTESVILLE MICRODEVICE FOR DIRECT DNA PURIFICATION Complete
2009 R21 RFA-CA-08-007 LIU, YANG UNIVERSITY OF PITTSBURGH AT PITTSBURGH PARTIAL-WAVE SPECTROSCOPIC MICROSCOPY FOR THE DIAGNOSIS OF CHOLANGIOCARCINOMA Complete
2013 R21 RFA-CA-12-002 JEFFREY, STEFANIE S. STANFORD UNIVERSITY A DROPLET-BASED SYSTEM FOR CAPTURE, MANIPULATION, AND BIOCHEMICAL PROFILING OF RA Complete
2016 R33 RFA-CA-15-003 SPICER, TIMOTHY PATRICK SCRIPPS FLORIDA ADVANCED DEVELOPMENT AND VALIDATION OF 3 DIMENSIONAL SPHEROID CULTURE OF PRIMARY CANCER CELLS USING NANO3D TECHNOLOGY Complete
2020 R21 RFA-CA-19-019 SEELIG, GEORG UNIVERSITY OF WASHINGTON High-resolution spatial transcriptomics through light patterning Complete
2000 R21 PAR-98-066 HAMPDEN-SMITH, MARK J SUPERIOR MICROPOWDERS, LLC UNIQUE, SMALL PARTICLE PHOSPHOR POWDERS FOR IMUNOASSAYS Complete
2002 R33 PAR-99-100 SUTHERLAND, JOHN CLARK BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB DNA DAMAGE QUANTITATION BY SINGLE MOLECULE LASER SIZING Complete
2005 R44 RFA-CA-05-006 RUSH, JOHN CELL SIGNALING TECHNOLOGY, INC. IMMUNOAFFINITY ISOLATION OF PHOSPHOPEPTIDES Complete
2008 R43 RFA-CA-07-041 CHAN, DOUG PROTECH LABORATORIES, INC. DEVELOPMENT AND APPLICATION OF TECHNOLOGY PLATFORM FOR IDENTIFICATION OF THE HIST Complete
2011 R33 RFA-CA-10-004 PORTER, MARC D UNIVERSITY OF UTAH ADVANCED DEVELOPMENT OF A MULTIPLEXED SERS-BASED BIOMARKER DETECTION PLATFORM: A Complete
2015 R43 PAR-13-327 SELIGMANN, BRUCE E. BIOSPYDER TECHNOLOGIES, INC. IN SITU RNA-FISH WITH LOCALIZED PROFILING BY SEQUENCING FROM FFPE Complete

Pages